The MMNI group is excited to participate in the very first Cologne Neuroscience Day (CNS) as a platform for young neuroscientists in Cologne to present their work. Talks will be given by Dr. Gérard N. Bischof and Dr. Jochen Hammes.
Read the full program here.
The medical faculty awards Dr. Jochen Hammes with a 12-month stipend for a research rotation at the MMNI lab to work on software-assisted PET analysis in neurodegenerative diseases.
Prof. Thilo van Eimeren will coordinate a Brain Imaging Working Group aiming to harmonize brain imaging approaches in atypical parkinsonian disorders. The project will be funded by the EU Joint Programme for Neurodegenerative Disease Research (JPND).
Read the project description here.
Every year, the Society of Nuclear Medicine and Molecular Imaging chooses an image that exemplifies the most promising advances in the field in order to detect diseases, aid diagnosis or select appropriate treatment strategies for patients. For this year’s annual meeting held in San Diego, the reviewers had to vote from 2200 submitted abstracts. We are happy and proud to announce that this year’s Image of the Year award goes to our dear member Dr. Gérard Bischof for his work entitled: “Novel PET imaging demonstrates relationship between Tau bildup and neurodegeneration in Alzheimer’s patients.”
Read the full article here. You can download the image here.
We were happy to host the first MINC symposium under the guiding theme “Imaging Biomarkers in Neurodegeneration: Are we prepared for therapy?” on June 24th – 25th 2016.
Find pictures and program here.
The medical faculty awards Kathrin Giehl an IPaK travel grant in the context of the ipid4all-application (DAAD) of the Albertus Magnus Graduate Center in order to present her work on T1-assisted tau-PET image preprocessing at the 22nd annual meeting of the Organization for Human Brain Mapping in Geneva, Switzerland.
The Organization for Human Brain Mapping (OHBM) honours Dr. Gérard N. Bischof’s work on the contribution of tau to neurodegeneration in Alzheimer’s disease with a Merit Abstract Award during their 22nd annual meeting in Geneva, Switzerland.